These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1302441)

  • 41. Effect of size and dosage strength on the bioavailability of two diltiazem formulations during repeated administrations in humans.
    Campistron G; Rostin M; Coulais Y; Caillard C; Zarrouk G; Frances J; Thiercellin JF; Montastruc JL; Houin G
    Fundam Clin Pharmacol; 1987; 1(1):67-75. PubMed ID: 3666663
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of the steady-state pharmacokinetics of immediate-release and controlled-release diltiazem tablets.
    Leeuwenkamp OR; Visscher HW; Mensink CK; Jonkman JH
    Eur J Clin Pharmacol; 1994; 46(3):243-7. PubMed ID: 8070505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Single-dose and steady-state pharmacokinetics of diltiazem administered in two different tablet formulations.
    Christrup LL; Bonde J; Rasmussen SN; Sonnergaard JM; Jensen BH
    Pharmacol Toxicol; 1992 Oct; 71(4):305-7. PubMed ID: 1454755
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bioequivalence of two pharmaceutical forms of diltiazem.
    Rubio M; Masana MI; Garcilazo E; de los Santos AR; di Girolamo G
    Biopharm Drug Dispos; 1990; 11(1):77-83. PubMed ID: 2322638
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender differences in exercise and recovery blood pressure responses in normal volunteers given diltiazem.
    Klassen GA; Yeung PF; Barclay KD; Hung OR; Pollak PT; Buckley SJ
    J Clin Pharmacol; 1995 Dec; 35(12):1144-9. PubMed ID: 8750364
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of food on the bioavailability of diltiazem and two of its metabolites following the administration of conventional tablets and slow-release capsules.
    Du Souich P; Lery N; Lery L; Varin F; Boucher S; Vezina M; Pilon D; Spenard J; Caillé G
    Biopharm Drug Dispos; 1990 Mar; 11(2):137-47. PubMed ID: 2328299
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacokinetics and hypotensive effect of deacetyl N-monodesmethyl diltiazem (M2) in rabbits after a single intravenous administration.
    Yeung PK; Feng JD; Buckley SJ
    Eur J Drug Metab Pharmacokinet; 1998; 23(1):27-31. PubMed ID: 9625269
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics and haemodynamic effect of diltiazem in rats: effect of route of administration.
    Tsui BC; Feng JD; Yeung PK
    J Pharm Pharmacol; 1998 Feb; 50(2):183-8. PubMed ID: 9530986
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prolongation of the PQ interval as a measure of therapeutic inequivalence between two formulations of diltiazem.
    Della Paschoa OE; Luckow V; Trenk D; Jähnchen E; Santos SR
    Eur J Clin Pharmacol; 1995; 48(1):45-9. PubMed ID: 7621847
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics of slow-release diltiazem and its effect on atrioventricular conduction in healthy volunteers.
    Gordin A; Pohto P; Sundberg S; Nykänen S; Haataja H; Männistö P
    Eur J Clin Pharmacol; 1986; 31(4):423-6. PubMed ID: 3816921
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Physiological disposition of intravenously administered 14C-labeled diltiazem in healthy volunteers.
    Höglund P; Nilsson LG
    Ther Drug Monit; 1988; 10(4):401-9. PubMed ID: 3201524
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk-based approach for systematic development of gastroretentive drug delivery system.
    Mirani AG; Patankar SP; Kadam VJ
    Drug Deliv Transl Res; 2016 Oct; 6(5):579-96. PubMed ID: 27468861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetic and pharmacodynamic properties of conventional and CD-formulated diltiazem in cats.
    Johnson LM; Atkins CE; Keene BW; Bai SA
    J Vet Intern Med; 1996; 10(5):316-20. PubMed ID: 8884718
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic analysis of two new sustained-release products of diltiazem designed for twice- and once-daily treatment.
    Bialer M; Hadad S; Golomb G; Barel S; Samara E; Abu Salach O; Berkman N; Danenberg HD; Ben David J; Caron D
    Biopharm Drug Dispos; 1994 Jan; 15(1):45-52. PubMed ID: 8161715
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of diltiazem and propranolol when administered alone and in combination.
    Dimmitt DC; Yu DK; Elvin AT; Giesing DH; Lanman RC
    Biopharm Drug Dispos; 1991 Oct; 12(7):515-23. PubMed ID: 1932613
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic and bioavailability of diltiazem sustained-release: influence of food and time of administration.
    Bianchetti G; Bagheri H; Houin G; Dubruc C; Thénot JP
    Fundam Clin Pharmacol; 1995; 9(2):197-201. PubMed ID: 7628834
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nifedipine: kinetics and dynamics in healthy subjects.
    Kleinbloesem CH; van Brummelen P; van de Linde JA; Voogd PJ; Breimer DD
    Clin Pharmacol Ther; 1984 Jun; 35(6):742-9. PubMed ID: 6734025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and pharmacodynamic effects of aqueous diltiazem in healthy humans.
    Fu M; Hung JS; Yeh SJ; Lin FC; Hsu RS; Wu D
    J Clin Pharmacol; 1987 Feb; 27(2):106-10. PubMed ID: 3680561
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Absorption of diltiazem in beagle dog from pulsatile release tablet.
    Ishino R; Yoshino H; Hirakawa Y; Noda K
    Chem Pharm Bull (Tokyo); 1992 Nov; 40(11):3094-6. PubMed ID: 1477926
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The pharmacokinetics and pharmacodynamics of diltiazem and its metabolites in healthy adults after a single oral dose.
    Boyd RA; Chin SK; Don-Pedro O; Verotta D; Sheiner LB; Williams RL; Giacomini KM
    Clin Pharmacol Ther; 1989 Oct; 46(4):408-19. PubMed ID: 2791444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.